YU45787B - Postupak za dobijanje 3-(supstituisanih)propenilaminotiazolil-cefalosporanski kiselina i njihovih estara - Google Patents

Postupak za dobijanje 3-(supstituisanih)propenilaminotiazolil-cefalosporanski kiselina i njihovih estara

Info

Publication number
YU45787B
YU45787B YU110086A YU110086A YU45787B YU 45787 B YU45787 B YU 45787B YU 110086 A YU110086 A YU 110086A YU 110086 A YU110086 A YU 110086A YU 45787 B YU45787 B YU 45787B
Authority
YU
Yugoslavia
Prior art keywords
formula
compound
group
hydrogen
defined above
Prior art date
Application number
YU110086A
Other languages
English (en)
Other versions
YU110086A (en
Inventor
S. Timura
Y. Abe
J. Okumura
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of YU110086A publication Critical patent/YU110086A/xx
Publication of YU45787B publication Critical patent/YU45787B/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

POSTUPAK ZA DOBIJANJE 3-(SUPSTITUISANIH)PROPENILAMINOTIAZOLIL-CEFALOSPORANSKI KISELINA I NJIHOVIH ESTARA, formule: u kojima je R1 vodonik ili amino-zascitna grupa kao sto je tricil; R2 je vodonik, C1-4 alkil, C2-4 alkenil, C2-4 alkinil ili C3-6 cikloalkil grupa, cikloalkilalkil grupa sa 3-6 ugljenikovih atoma u prstenu i ukupno 4-10 ugljenikovih atoma, ili C2-4 alkanoil grupa; R3 je vodonik, C1-3 alkil ili C2-3 alkanoiloksi; i R4 je vodonik ili estarska grupa koja podleze fizioloskoj hidrolizi, kao sto je acetoksimetil, 1-acetoksietil, pivaloiloksimetil, 5-metil-2-okso-1,3-dioksolen-4-ilmetil, 1-(etoksikarboniloksi)etil ili 4-gliciloksi-benzoiloksimetil, naznacen time, sto jedinjenje formule: u kojoj R5 predstavlja grupu formule: gde je R1' amino zastitna grupa kao sto je tricil; R2a je hidroksi-zastitna grupa kao sto je tricil, hloroacetil, formil, trihloroetoksikarbonil, terc-butoksikarbonil ili karbobenziloksi, ili ima jedno od znacenja dato za R2, osim vodonika; i R4' je karboksi-zastitna grupa kao sto je difenilmetil, reaguje sa aldehidom formule: R3CH2CHO u kojoj je R3 kao sto je definisano gore, u inertnom organskom reakcionom medijumu kao sto je dihlorometan, N,N'-dimetilformamid, izopropanol ili smesa ovih rastvaraca, po potrebi u prisustvu litijum hlorida, litijum bromida ili litijum jodida, na temperaturi od oko 0 do 25 C, tako da se dobija jedinjenje formule: u kojoj su R3, R5 i R4', kao sto je definisano gore; sto se, kada R5 predstavlja grupu formule (XVI), vrsi njena selektivna hidroliza u prisustvu kiseline kao sto je HCl, na sobnoj temperaturi, nakon cega se, po potrebi, 3-(Z)-izomer dobijenog 7-amino intermedijera prevodi u 3-(E)-izomer fotohemijskom reakcijom, u rastvaracu kao sto je metanol i u prisustvu senzibilizatora kao sto je benzofenon, na sobnoj temperaturi, i zatim se 7-amino intermedijer aciluje sa jedinjenjem formule: ili njegovim aktiviranim derivatom kao sto je anhidrid ili hlorid, u rastvaracu kao sto je dihlorometan i na temperaturi od oko -10 C do sobne, da bi se dobilo jedinjenje formule: pri cemu su R3, R1', R2a i R4' kao sto je definisano gore; sto se u jedinjenju formule (XIX) uklanjaju zastitne grupe R1, R2a i R4' reakcijom sa kiselinom, kao sto je trifluorosircetna kiselina, po potrebi u prisustvu anizola, i sto se, po potrebi, vrsi odvajanje 3-(Z)- i 3-(E)-izomera, da bi se dobilo jedinjenje formule: u kojoj su R1, R2 i R3 kao sto je definisano gore; i sto, po potrebi, alkalnometalna ili amonijumova so jedinjenja formule (Ia) reaguje sa halogenidom formule: R4b-X u kojoj X predstavlja hloro, bromo ili jodo, a R4b je estarska grupa koja podleze fizioloskoj hidrolizi, kao sto je acetoksimetil, 1-acetoksietil, pivaloiloksimetil, 5-metil-2-okso-1,3-dioksolen-4-ilmetil, 1-(etoksikarboniloksi)etil ili 4-gliciloksibenzoiloksimetil, da bi se dobio estar formule: u kojoj R4 ima znacenje kao sto je definisano gore, razlicito od vodonika.
YU110086A 1985-06-24 1986-06-24 Postupak za dobijanje 3-(supstituisanih)propenilaminotiazolil-cefalosporanski kiselina i njihovih estara YU45787B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/748,359 US4708955A (en) 1985-06-24 1985-06-24 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof

Publications (2)

Publication Number Publication Date
YU110086A YU110086A (en) 1987-10-31
YU45787B true YU45787B (sh) 1992-07-20

Family

ID=25009129

Family Applications (1)

Application Number Title Priority Date Filing Date
YU110086A YU45787B (sh) 1985-06-24 1986-06-24 Postupak za dobijanje 3-(supstituisanih)propenilaminotiazolil-cefalosporanski kiselina i njihovih estara

Country Status (36)

Country Link
US (1) US4708955A (sh)
JP (1) JPS62491A (sh)
KR (1) KR930007416B1 (sh)
AR (1) AR244233A1 (sh)
AT (1) AT390956B (sh)
AU (1) AU593557B2 (sh)
BE (1) BE904983A (sh)
CA (1) CA1279868C (sh)
CS (1) CS258142B2 (sh)
CY (1) CY1618A (sh)
DD (1) DD246112A5 (sh)
DE (1) DE3620995A1 (sh)
DK (1) DK295386A (sh)
EG (1) EG17868A (sh)
ES (1) ES8800680A1 (sh)
FI (1) FI85487C (sh)
FR (1) FR2583757B1 (sh)
GB (1) GB2178032B (sh)
GR (1) GR861611B (sh)
HK (1) HK106091A (sh)
HU (1) HU199484B (sh)
IE (1) IE59123B1 (sh)
IL (1) IL79181A0 (sh)
IT (1) IT1221767B (sh)
LU (1) LU86488A1 (sh)
MY (1) MY102073A (sh)
NL (1) NL8601645A (sh)
NZ (1) NZ216614A (sh)
OA (1) OA08349A (sh)
PH (2) PH21206A (sh)
PT (1) PT82836B (sh)
SE (1) SE500218C2 (sh)
SG (1) SG91691G (sh)
SU (1) SU1428204A3 (sh)
YU (1) YU45787B (sh)
ZA (1) ZA864297B (sh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874856A (en) * 1985-06-24 1989-10-17 Bristol-Myers Company 3-(substituted)propenyl-7-(aminothiazolylacetamido) ceph-3-em-4-carboxylic acids and esters thereof
GB8519606D0 (en) * 1985-08-05 1985-09-11 Fujisawa Pharmaceutical Co 3 7-d substituted-3-cephem compounds
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
FR2622585B1 (fr) * 1987-11-03 1991-04-19 Roussel Uclaf Nouvelles cephalosporines comportant en position 3 un radical vinyle substitue, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
US4935508A (en) * 1988-08-23 1990-06-19 Bristol-Myers Company Process for cephem prodrug esters
US5143911A (en) * 1990-08-23 1992-09-01 Bristol-Myers Squibb Company Antibiotic c-3 di-hydroxyphenyl substituted cephalosporin compounds, compositions and method of use thereof
JP2825655B2 (ja) * 1992-02-05 1998-11-18 バイオケミ・ゲゼルシヤフト・エム・ベー・ハー 3−セフェム−4−カルボン酸誘導体の精製方法
JPH07173168A (ja) * 1993-07-14 1995-07-11 Sumitomo Chem Co Ltd セフェム系化合物、その製法、およびそれのセフェム系抗生物質製造への利用
KR100408430B1 (ko) * 2001-04-18 2003-12-06 한미약품 주식회사 3-(z)-프로페닐 세펨 화합물의 선택적인 제조 방법
WO2005042543A1 (en) * 2003-10-30 2005-05-12 Cj Corporation Processes for the preparation of cephem derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917778A (en) * 1968-04-13 1975-11-04 Tdk Electronics Co Ltd Method for slip casting soft ferromagnetic ferrites
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4065620A (en) * 1971-06-14 1977-12-27 Eli Lilly And Company 3-(Substituted) vinyl cephalosporins
FR2345153A1 (fr) * 1976-03-25 1977-10-21 Roussel Uclaf Nouvelles alcoyloximes derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
US4464369A (en) * 1977-03-14 1984-08-07 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-cephem-4-carboxylic acid derivatives and pharmaceutical compositions
GB2051788B (en) * 1979-05-23 1984-01-18 Rhone Poulenc Ind 3 - thiovinyl - cephalosporins their preparation and compositions containing them
FR2457296A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2457297A1 (fr) * 1979-05-23 1980-12-19 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
FR2494275A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de vinyl-3 cephalosporines et leur preparation
FR2494276A2 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouvelles vinyl-3 cephalosporines, et leur preparation
FR2494280A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine et leur preparation
IE53429B1 (en) * 1981-08-03 1988-11-09 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
DK162718C (da) * 1982-09-30 1992-05-11 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af 7-substitueret-3-vinyl-3-cephemforbindelser
GB8323034D0 (en) * 1983-08-26 1983-09-28 Fujisawo Pharmaceutical Co Ltd 7-substituted-3-vinyl-3-cephem compounds
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives
CA1276929C (en) * 1984-04-09 1990-11-27 Masahisa Oka Cephalosporin antibacterial agents
GB8411954D0 (en) * 1984-05-10 1984-06-13 Glaxo Group Ltd Cephalosporin antibiotics
FR2580652B1 (fr) * 1985-04-22 1989-01-06 Bristol Myers Co Acide 7-amino-3-propenylcephalosporanique et ses esters

Also Published As

Publication number Publication date
NZ216614A (en) 1990-03-27
HUT43074A (en) 1987-09-28
GB2178032A (en) 1987-02-04
US4708955A (en) 1987-11-24
SE8602780L (sv) 1986-12-25
CY1618A (en) 1992-07-10
GB2178032B (en) 1989-04-26
FI862642A (fi) 1986-12-25
IT8620894A0 (it) 1986-06-24
AU593557B2 (en) 1990-02-15
PH21206A (en) 1987-08-19
PT82836A (en) 1986-07-01
ATA171986A (de) 1990-01-15
NL8601645A (nl) 1987-01-16
PH21879A (en) 1988-03-25
IT1221767B (it) 1990-07-12
DK295386D0 (da) 1986-06-23
GR861611B (en) 1986-10-30
AR244233A1 (es) 1993-10-29
FI85487C (fi) 1992-04-27
IL79181A0 (en) 1986-09-30
CA1279868C (en) 1991-02-05
FI85487B (fi) 1992-01-15
CS258142B2 (en) 1988-07-15
PT82836B (pt) 1989-01-17
OA08349A (fr) 1988-02-29
SE500218C2 (sv) 1994-05-09
YU110086A (en) 1987-10-31
LU86488A1 (fr) 1987-01-13
FR2583757B1 (fr) 1989-01-13
ES556465A0 (es) 1987-11-01
SG91691G (en) 1991-12-13
JPS62491A (ja) 1987-01-06
DD246112A5 (de) 1987-05-27
AU5882186A (en) 1987-01-08
HU199484B (en) 1990-02-28
SU1428204A3 (ru) 1988-09-30
AT390956B (de) 1990-07-25
DE3620995A1 (de) 1987-01-08
MY102073A (en) 1992-03-31
IE59123B1 (en) 1994-01-12
FI862642A0 (fi) 1986-06-19
ZA864297B (en) 1987-02-25
EG17868A (en) 1994-01-30
FR2583757A1 (fr) 1986-12-26
BE904983A (fr) 1986-12-23
HK106091A (en) 1992-01-03
SE8602780D0 (sv) 1986-06-23
IE861670L (en) 1986-12-24
CS462486A2 (en) 1987-11-12
GB8615253D0 (en) 1986-07-30
KR870000342A (ko) 1987-02-18
DK295386A (da) 1986-12-25
ES8800680A1 (es) 1987-11-01
KR930007416B1 (ko) 1993-08-10

Similar Documents

Publication Publication Date Title
YU45787B (sh) Postupak za dobijanje 3-(supstituisanih)propenilaminotiazolil-cefalosporanski kiselina i njihovih estara
AU575927B2 (en) Optically active alkyl-aryl ketals and the preparation of alpha-aryly alkanoic acids
PH21987A (en) Process for producing novel penicillins and cephalosporins
KR860008181A (ko) 7-치환된 바이시클릭 피라졸리디논의 제조방법
US3578660A (en) 2-acyloxycephalosporin compounds
US3923795A (en) 2-Alkoxycephalosporins
US3963712A (en) 3-Halo-cephalosporins
ATE126230T1 (de) Cephalosporinderivate und verfahren zur herstellung von cephem-verbindungen.
JPS54128591A (en) Cephalosporin analog
US3647787A (en) Process improvement for converting penicillin sulfoxide esters to cephem compounds
EP0117872B1 (en) Process for preparing cephalosporin compounds
GB1431486A (en) Process for the manufacture of 6-aminopenicillanic acids and 7-aminocephalosporanic acids
JPS5239694A (en) Producing novel penicillins and cephalosporins
SU471723A3 (ru) Способ получени производных пенициллина
US4085113A (en) Process for the preparation of azetidinone-thiazoline precursors for cephalosporin synthesis
Murphy et al. Alteration of the dihydrothiazine ring moiety
JPS54103888A (en) Novel 7alpha-methoxy-cephalosporin
US3707540A (en) 1,3-thiazines and their preparation
US3704291A (en) Penicillins derived from the reaction of enamines with 6-isocyanato penicillanic acid
GB1576414A (en) Anti-bacterially-active penicillins
EG14458A (en) Branched salkyl phosphonodithioic halide intermediates and process for their production
ES423178A1 (es) Procedimiento para la preparacion de esteres acilamidometi-licos de penicilinas y cefalosporinas.
US4508658A (en) Pentahalophenyl ester of cyanoacetic acid derivatives
GB2050380B (en) Phosphorus containing compounds used in the preparation of cephalosporins
ATE98248T1 (de) Verfahren zur herstellung von cephalosporinderivaten.